Finance

Lists
000650:SHE
Renhe Pharmacy Co Ltd
CNÂ¥5.18
0.00%
(0.00) 1D
Sep 18, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000650...
Open
CNÂ¥5.19
High
CNÂ¥5.24
Low
CNÂ¥5.18
Mkt. cap
7.25B
Avg. vol.
21.25M
Volume
9.91M
Dividend
2.93%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 17, 2026
P/E ratio
18.37
52-wk high
CNÂ¥6.65
52-wk low
CNÂ¥4.85
EPS
CNÂ¥0.28
Shares outstanding
1.40B
No. of employees
5K
Open
CNÂ¥5.19
High
CNÂ¥5.24
Low
CNÂ¥5.18
Mkt. cap
7.25B
Avg. vol.
21.25M
Volume
9.91M
Dividend
2.93%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 17, 2026
P/E ratio
18.37
52-wk high
CNÂ¥6.65
52-wk low
CNÂ¥4.85
EPS
CNÂ¥0.28
Shares outstanding
1.40B
No. of employees
5K
About Renhe Pharmacy Co Ltd
CEO-
Employees4.92K
Founded1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
858.36M
702.97M
1.13B
961.72M
Cost of goods sold
546.74M
441.40M
714.76M
624.22M
Cost of revenue
546.74M
441.40M
714.76M
624.22M
Research and development expenses
5.77M
18.66M
7.45M
7.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.04M
114.98M
161.19M
133.43M
Operating expense
93.94M
254.84M
175.05M
149.31M
Total operating expenses
640.69M
696.24M
889.81M
773.53M
Operating income
217.67M
6.73M
239.42M
188.19M
Other non operating income
-1.54M
-250.82K
-108.00K
-7.29M
EBT including unusual items
154.90M
48.84M
242.91M
221.96M
EBT excluding unusual items
228.71M
52.18M
245.45M
190.09M
Income tax expense
41.03M
30.30M
64.68M
44.81M
Effective tax rate
26.49%
62.03%
26.63%
20.19%
Other operating expenses
-78.87M
97.31M
6.41M
8.10M
Net income
88.71M
14.07M
140.37M
151.57M
Net profit margin
10.33%
2.00%
12.43%
15.76%
Earnings per share
-
-
-
-
Interest and investment income
12.60M
45.72M
6.16M
9.19M
Interest expense
-19.85K
-23.77K
-18.40K
-
Net interest expenses
12.58M
45.70M
6.14M
9.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
246.62M
35.39M
268.07M
217.28M
Gain or loss from assets sale
2.00M
-2.05M
-
41.58K
AI content may include mistakes. Learn more
Google apps